Brant Firestone

2.8k total citations
9 papers, 197 citations indexed

About

Brant Firestone is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Brant Firestone has authored 9 papers receiving a total of 197 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Brant Firestone's work include Cell death mechanisms and regulation (3 papers), Peptidase Inhibition and Analysis (2 papers) and Ubiquitin and proteasome pathways (2 papers). Brant Firestone is often cited by papers focused on Cell death mechanisms and regulation (3 papers), Peptidase Inhibition and Analysis (2 papers) and Ubiquitin and proteasome pathways (2 papers). Brant Firestone collaborates with scholars based in United States, Spain and Australia. Brant Firestone's co-authors include Leigh Zawel, Dale Porter, Joanna Slisz, Girija Goyal, Weibo Li, Dobrin Draganov, Glenn Dranoff, Stephanie K. Dougan, Richard S. Blumberg and Nir Hacohen and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Cell Biology and Blood.

In The Last Decade

Brant Firestone

9 papers receiving 191 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brant Firestone United States	5	116	86	79	43	29	9	197
Héléna Boutzen France	8	234 2.0×	61 0.7×	61 0.8×	65 1.5×	39 1.3×	11	329
Eva Pérez‐Guijarro United States	5	166 1.4×	78 0.9×	57 0.7×	76 1.8×	49 1.7×	7	264
Yanyun Du China	10	176 1.5×	62 0.7×	60 0.8×	67 1.6×	52 1.8×	19	286
Tonantzin G. Calvo Spain	4	122 1.1×	69 0.8×	35 0.4×	78 1.8×	28 1.0×	5	212
Christy M. Gearheart United States	7	194 1.7×	47 0.5×	47 0.6×	117 2.7×	51 1.8×	11	287
Tommaso Perini Italy	8	156 1.3×	35 0.4×	60 0.8×	65 1.5×	18 0.6×	19	263
Mallika Ramakrishnan Germany	8	134 1.2×	80 0.9×	134 1.7×	53 1.2×	79 2.7×	8	299
Umberto Rosato United States	4	115 1.0×	112 1.3×	106 1.3×	49 1.1×	26 0.9×	4	258
Mareike Wittenbrink Germany	5	73 0.6×	305 3.5×	180 2.3×	29 0.7×	25 0.9×	5	366
Shoua Yang United States	8	127 1.1×	137 1.6×	78 1.0×	19 0.4×	63 2.2×	9	258

Countries citing papers authored by Brant Firestone

Since Specialization

Citations

This map shows the geographic impact of Brant Firestone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brant Firestone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brant Firestone more than expected).

Fields of papers citing papers by Brant Firestone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brant Firestone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brant Firestone. The network helps show where Brant Firestone may publish in the future.

Co-authorship network of co-authors of Brant Firestone

This figure shows the co-authorship network connecting the top 25 collaborators of Brant Firestone. A scholar is included among the top collaborators of Brant Firestone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brant Firestone. Brant Firestone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Honda, Ayako, Edmund Harrington, Iván Cornella‐Taracido, et al.. (2015). Potent, Selective, and Orally Bioavailable Inhibitors of VPS34 Provide Chemical Tools to Modulate Autophagy in Vivo. ACS Medicinal Chemistry Letters. 7(1). 72–76. 40 indexed citations

Vidal, Laura, Stephen Chia, David Porter, et al.. (2012). Abstract P6-11-06: A phase Ib study of LCL161, an oral inhibitor of apoptosis (IAP) antagonist, in combination with weekly paclitaxel in patients with advanced solid tumors. Cancer Research. 72(24_Supplement). P6–11. 9 indexed citations

Firestone, Brant. (2010). The challenge of selecting the ‘right’ in vivo oncology pharmacology model. Current Opinion in Pharmacology. 10(4). 391–396. 15 indexed citations

Huang, Alan, Yan Chen, Xiaoyan Li, et al.. (2010). Abstract 4443: Molecular mechanistic study of ASA404 (vadimezan)-induced endothelial cell death. Cancer Research. 70(8_Supplement). 4443–4443. 1 indexed citations

Dougan, Michael, Stephanie K. Dougan, Joanna Slisz, et al.. (2010). IAP inhibitors enhance co-stimulation to promote tumor immunity. The Journal of Experimental Medicine. 207(10). 2195–2206. 114 indexed citations

Dougan, Michael, Stephanie K. Dougan, Joanna Slisz, et al.. (2010). IAP inhibitors enhance co-stimulation to promote tumor immunity. The Journal of Cell Biology. 190(6). i13–i13. 1 indexed citations

Firestone, Brant, Guizhi Yang, Hui Gao, et al.. (2009). Abstract B27: Correlation between TNFα and LCL161 anti-tumor activity in patient derived xenograft models of human cancer. Molecular Cancer Therapeutics. 8(12_Supplement). B27–B27. 11 indexed citations

Growney, Joseph D., Peter Atadja, Wenlin Shao, et al.. (2007). Efficacy of Panobinostat (LBH589) in Multiple Myeloma Cell Lines and In Vivo Mouse Model: Tumor-Specific Cytotoxicity and Protection of Bone Integrity in Multiple Myeloma.. Blood. 110(11). 1510–1510. 3 indexed citations

Jain, Jugnu, Jianguo Ma, Brinley F. Furey, et al.. (2004). The IMPDH Inhibitor VX-944 Demonstrates In Vivo Efficacy in an Aggressive Leukemia Model.. Blood. 104(11). 2530–2530. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact